Aspirin Has Little Benefit for Many With Heart Disease
Close to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an anti platelet response from aspirin, the effect expected to be protective. The University of Buffalo conducted a strictly controlled study over 29 months with 653 patients to confirm the 20 percent rate of aspirin resistance. Lead researcher, Francis Gengo, states, "Millions of people use low-dose aspirin for prevention of a second stroke, second heart attack, or second episode of peripheral artery disease. In those indications, it's crystal clear that aspirin reduces the risk of a second heart attack or stroke in most patients. But we have known for years that in some stroke and heart attack patients, aspirin has no preventative effect." (Read more about Aspirin Has Little Benefit for Many With Heart Disease)
Related Links:
|